Cipla Q4 PAT may dip 24.9% YoY to Rs 869.4 cr: ICICI Securities

ICICI Securities has come out with its fourth quarter (January - March’ 24) earnings estimates for the PHARMA sector. The brokerage house expects Cipla to report net profit at Rs 869.4 crore down 24.9% year-on-year (up 49.9% quarter-on-quarter).

Net Sales are expected to decrease by 4.7 percent Y-o-Y (up 9.6 percent Q-o-Q) to Rs 6,290.9 crore, according to ICICI Securities.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 23.7 percent Y-o-Y (up 13.6 percent Q-o-Q) to Rs 1,333.7 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.